G.Barekat Pharm (XTEH:BRKT1) Total Stockholders Equity : IRR5,003,506 Mil (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Stockholders Equity?

G.Barekat Pharm's Total Stockholders Equity for the quarter that ended in Mar. 2017 was IRR5,003,506 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. G.Barekat Pharm's Book Value per Share for the quarter that ended in Mar. 2017 was IRR916.51. The ratio of a company's debt over equity can be used to measure how leveraged this company is. G.Barekat Pharm's Debt-to-Equity for the quarter that ended in Mar. 2017 was 2.11.

G.Barekat Pharm Total Stockholders Equity Historical Data

The historical data trend for G.Barekat Pharm's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Stockholders Equity Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Total Stockholders Equity

5,003,506.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Total Stockholders Equity	-	5,003,506.00

G.Barekat Pharm (XTEH:BRKT1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

G.Barekat Pharm's Book Value per Share for the quarter that ended in Mar. 2017 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(5003506	-	0)	/	5459.31
	=	916.51

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

G.Barekat Pharm's Debt-to-Equity for the quarter that ended in Mar. 2017 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10315378	+	255897)	/	5003506
	=	2.11

G.Barekat Pharm Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines